Filter
586
Filtered Results: 586
Text search:
antimalarial
drugs
Featured
Recommendations
67
New Publications
231
Language
Document type
No document type
382
Studies & Reports
71
Guidelines
70
Manuals
25
Training Material
12
Strategic & Response Plan
11
Fact sheets
10
Situation Updates
4
Infographics
1
Countries / Regions
Uganda
34
Sierra Leone
31
India
30
Kenya
25
Ethiopia
23
Liberia
22
Nigeria
22
Ghana
20
Malawi
18
Zambia
16
Tanzania
15
Rwanda
15
Global
15
Senegal
11
Nepal
11
Philippines
8
Cameroon
7
Zimbabwe
7
Latin America and the Carribbean
7
Africa
7
Burkina Faso
6
Cambodia
6
South Africa
6
Mozambique
6
Indonesia
5
Bangladesh
5
Namibia
5
Myanmar / Burma
5
South–East Asia Region
5
Congo, Democratic Republic of
4
South Sudan
3
Eswatini/ Swaziland
3
Brazil
3
Botswana
3
East and Southern Africa
3
Western and Central Europe
3
Somalia
2
Pakistan
2
Thailand
2
Central African Republic
2
West and Central Africa
2
Middle East and North Africa
2
Venezuela
2
Vietnam
2
Haiti
1
Lebanon
1
Turkey
1
Papua New Guinea
1
Argentina
1
Peru
1
Colombia
1
Bolivia
1
Libya
1
Lesotho
1
Chile
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Eastern Europe
1
Southern Africa
1
Laos
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
338
Clinical Guidelines
75
Women & Child Health
35
Public Health
22
Key Resources
13
Capacity Building
11
Pharmacy & Technologies
11
Toolboxes
AMR
38
Pharmacy
37
Ebola
20
HIV
15
NTDs
14
Rapid Response
10
COVID-19
8
TB
7
Caregiver
6
Health Financing Toolbox
5
Disability
4
Planetary Health
4
Conflict
3
Refugee
3
Mental Health
3
Global Health Education
3
Polio
2
Natural Hazards
2
Cholera
1
Zika
1
Health Financing
1
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
Decree of the Minister of Health of the Republic of Indonesia No. 2500 / MENKES / SK / XII / 2011 on National Essential Medicines List 2011
Regulation of the Minister of Health of the Republic of Indonesia on Guidelines for Antiretroviral Treatment
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for ...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato...
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate ...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
